Franklin Resources
TNGX icon

Franklin Resources’s Tango Therapeutics TNGX Stock Holding History

Franklin Resources’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$59M Buy
1,887,211
+590,928
+46% +$14.6M 0.01% 622
2026
Q1 		$27.1M Sell
1,296,283
-101,774
-7% -$1.42M 0.01% 867
2025
Q4 		$12.4M Buy
1,398,057
+471,153
+51% +$4.06M ﹤0.01% 1101
2025
Q3 		$7.79M Buy
926,904
+801,697
+640% +$5.43M ﹤0.01% 1250
2025
Q2 		$641K Buy
125,207
+342
+0.3% +$846 ﹤0.01% 2210
2025
Q1 		$171K Sell
124,865
-1,688
-1% -$4.15K ﹤0.01% 2729
2024
Q4 		$391K Buy
126,553
+110,126
+670% +$511K ﹤0.01% 2400
2024
Q3 		$112K Sell
16,427
-9,021
-35% -$86.1K ﹤0.01% 2736
2024
Q2 		$218K Buy
25,448
+2,919
+13% +$22.6K ﹤0.01% 2543
2024
Q1 		$179K Sell
22,529
-1,554
-6% -$16.7K ﹤0.01% 2619
2023
Q4 		$238K Buy
+24,083
New +$209K ﹤0.01% 2282

Other funds holding TNGX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Franklin Resources's TNGX Position: Q2 2026 in Review

Franklin Resources increased its Tango Therapeutics (TNGX) stake by 46% in Q2 2026, buying an estimated $14.6M and bringing the position to 1,887,211 shares worth $59M. The position accounts for 0.01% of the portfolio, ranked #622.

Franklin Resources first reported a position in TNGX in Q4 2023 and has held it in 11 quarters since. 247 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

  • Franklin Resources held 1,887,211 shares of Tango Therapeutics worth $59M as of Q2 2026.
  • Franklin Resources bought 590,928 Tango Therapeutics shares in Q2 2026, an estimated $14.6M.
  • Tango Therapeutics made up 0.01% of Franklin Resources's portfolio in Q2 2026, its #622 holding.
  • Franklin Resources first reported a position in Tango Therapeutics in Q4 2023 and has held it in 11 quarters since.
  • 247 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.